Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Kasem S. Akhras"'
Publikováno v:
International journal of technology assessment in health care. 39(1)
The launch of innovative technologies has been credited with significant improvements in health indicators, but it comes at a high financial impact, and the value of certain innovations may not be well documented. Health technology assessment (HTA) i
Autor:
Georgia Colville Parkin, Bregtje Kamphuis, Anna-Maria Fontrier, Shadi Saleh, Panos Kanavos, Kasem S. Akhras
Publikováno v:
Health policy (Amsterdam, Netherlands). 124(12)
In this paper we outline and compare pharmaceutical pricing policies for in-patent prescription pharma- ceuticals with emphasis on external reference pricing (ERP) in eleven countries across the Middle East and North Africa (MENA) region and explore
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 19(3)
INTRODUCTION Real-world evidence (RWE) is increasingly being used in coverage, reimbursement and formulary decisions for medicines globally. Areas covered: The Middle East (ME) region is significantly behind in generating and using RWE in health poli
Autor:
Breanna Essoi, Haridarshan Patel, Atul R Mahableshwarkar, Jennifer C. Samp, Jiao Yang, Jonathan Kurlander, Kasem S Akhras, Valery Walker
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 21:742-752
Major depressive disorder is one of the most common and disabling mental health disorders and is associated with substantial costs in terms of direct health care utilization and workplace productivity. Cognitive dysfunction, which alone substantially
Autor:
Zoltán Kaló, Panos Kanavos, Ola Ghaleb Al Ahdab, Abdulaziz H Al-Saggabi, Zoltán Vokó, Hamad S Alsultan, Maryam S. Alowayesh, Vito Luigi Tanzi, Faleh Mohamed Hussain Ali, Ibrahim Alabbadi, Mahmoud Elmahdawy, Kasem S Akhras, Gihan Hamdy Elsisi, Daoud Al-Badriyeh
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 15:993-998
Introduction: External price referencing (EPR) is applied frequently to control pharmaceutical prices. Our objective was to analyse how EPR is used in Middle Eastern (ME) countries and to compare the price corridor for original pharmaceuticals to non
Autor:
Fatma Zahra, Mondher Toumi, Jennifer Samp, Imen Soussi, Amna Kooli, Nadia Bakkour, Kasem S Akhras, Emna El Hammi, Gérard Duru
Publikováno v:
Psychiatry Research. 216:291-302
Cognitive dysfunction is increasingly recognized as a symptom in mental conditions including schizophrenia, major depressive disorder (MDD), and bipolar disorder (BPD). Despite the many available cognitive assessment instruments, consensus is lacking
Publikováno v:
Postgraduate Medicine. 126:65-75
Febuxostat is recommended as 1 of 2 first-line urate-lowering therapies (ULT) for treating gout in the 2012 American College of Rheumatology Guidelines. Several efficacy trials have compared febuxostat with allopurinol treatment, but real-world compa
Autor:
Jennifer Samp, Alexandre Vimont, Cécile Rémuzat, W Belgaied, Emna El Hammi, Amna Kooli, Samuel Aballéa, Mondher Toumi, Kasem S Akhras
Publikováno v:
European Neuropsychopharmacology. 24:133-141
As more evidence points to the association of cognitive dysfunction with mental health disorders, the assessment of cognitive function in routine clinical care of these disorders is increasingly important. Despite this, it remains unknown how cogniti
Autor:
Jennifer Samp, Michel Lamure, Emna El Hammi, Kasem S Akhras, Samuel Aballéa, Mondher Toumi, Cécile Rémuzat, Amna Kooli, Jean-Paul Auray
Publikováno v:
Therapeutic Advances in Psychopharmacology. 4:22-29
Background: Many studies have suggested that major depressive disorder (MDD) is often associated with cognitive dysfunction. Despite this, guidance addressing assessment of cognitive dysfunction in MDD is lacking. The aim of this study was to examine
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 16(1)
Thank you for giving us the opportunity to respond to Dr JL Carapinha’s letter [1].While we respect Carapinha’s argument that we provided few new insights on external price referencing (EPR) mechan...